Evidence map›Paper›PMID 31861297›Full record

ArticleInternational journal of molecular sciences2019

Inhibition of Protein Prenylation of GTPases Alters Endothelial Barrier Function.

Muhammad Aslam, Christian Troidl, Christian Tanislav, Susanne Rohrbach, Dursun Gündüz, Christian W Hamm

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Muhammad AslamDepartment of Cardiology/Angiology, University Hospital Giessen, 35392 Giessen, Germany.ORCID 0000-0002-8529-4217
Christian TroidlDepartment of Cardiology/Angiology, University Hospital Giessen, 35392 Giessen, Germany.
Christian TanislavDepartment of Neurology, Evangelisches Jung Stilling Krankenhaus GmbH, 57074 Siegen, Germany.
Susanne RohrbachInstitute of Physiology, Justus Liebig University, 35392 Giessen, Germany.
Dursun GündüzDepartment of Cardiology/Angiology, University Hospital Giessen, 35392 Giessen, Germany.
Christian W HammDepartment of Cardiology/Angiology, University Hospital Giessen, 35392 Giessen, Germany.
Justus-Liebig-Universität Gießen · DEUniversitätsklinikum Gießen und Marburg · DEDiakonie Klinikum Jung-Stilling · DE

Funding

Justus Liebig Universität Gießen 62589122
6 · The paper itself

Abstract

The members of Rho family of GTPases, RhoA and Rac1 regulate endothelial cytoskeleton dynamics and hence barrier integrity. The spatial activities of these GTPases are regulated by post-translational prenylation. In the present study, we investigated the effect of prenylation inhibition on the endothelial cytoskeleton and barrier properties. The study was carried out in human umbilical vein endothelial cells (HUVEC) and protein prenylation is manipulated with various pharmacological inhibitors. Inhibition of either complete prenylation using statins or specifically geranylgeranylation but not farnesylation has a biphasic effect on HUVEC cytoskeleton and permeability. Short-term treatment inhibits the spatial activity of RhoA/Rho kinase (Rock) to actin cytoskeleton resulting in adherens junctions (AJ) stabilization and ameliorates thrombin-induced barrier disruption whereas long-term inhibition results in collapse of endothelial cytoskeleton leading to increased basal permeability. These effects are reversed by supplementing the cells with geranylgeranyl but not farnesyl pyrophosphate. Moreover, long-term inhibition of protein prenylation results in basal hyper activation of RhoA/Rock signaling that is antagonized by a specific Rock inhibitor or an activation of cAMP signaling. In conclusion, inhibition of geranylgeranylation in endothelial cells (ECs) exerts biphasic effect on endothelial barrier properties. Short-term inhibition stabilizes AJs and hence barrier function whereas long-term treatment results in disruption of barrier properties.

Indexed as

Cell Membrane PermeabilityCytoskeletonEndothelial CellsEndotheliumGTP PhosphohydrolasesHumansIntercellular JunctionsModels, BiologicalProtein Prenylationrho-Associated KinasesGTP Phosphohydrolasesrho-Associated Kinasesadherens junctionsendothelial permeabilitygeranylgeranyl transferaseperipheral actinRac1RhoAstatins

Identifiers

PMID31861297
PMCPMC6981884
OpenAlexW2996456074

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.